Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance

K Almind, SK Frederiksen, MG Ahlgren, S Urhammer… - Diabetologia, 1998 - Springer
K Almind, SK Frederiksen, MG Ahlgren, S Urhammer, T Hansen, JO Clausen, O Pedersen
Diabetologia, 1998Springer
The family of insulin receptor substrates (IRS1–4) is defined by proteins with an overall
similar structure. IRS-1 and IRS-2 have been shown to have key roles in cellular
transmission of the action of insulin, insulin-like growth factor-1 and various cytokines. We
have previously identified amino acid polymorphisms in the human IRS-1 and IRS-2
proteins. Given the documented importance of IRS-1 and–2 in insulin signalling and the
implications of distribution of these genes for the pathogenesis of insulin resistance and …
Summary
The family of insulin receptor substrates (IRS1–4) is defined by proteins with an overall similar structure. IRS-1 and IRS-2 have been shown to have key roles in cellular transmission of the action of insulin, insulin-like growth factor-1 and various cytokines. We have previously identified amino acid polymorphisms in the human IRS-1 and IRS-2 proteins. Given the documented importance of IRS-1 and –2 in insulin signalling and the implications of distribution of these genes for the pathogenesis of insulin resistance and diabetes, we decided that the most recently identified member of the IRS family, IRS-4, was a relevant candidate to examine for genetic variability which might be associated with subsets of diabetes or insulin resistance. The gene encoding IRS-4 was analysed by the single strand conformation polymorphism technique in 83 Danish Caucasians with Type II (non-insulin-dependent) diabetes mellitus. Five amino acid polymorphisms were identified: Leu34Phe, Arg411Gly, Gly584Cys, His879Asp and Lys883Thr. In an association study of 324 patients with Type II diabetes and 267 control subjects with normal glucose tolerance the polymorphism at codon 34 was found with allelic frequencies of 3.9 and 2.3 %, respectively, the variant at codon 411 with allelic frequencies of 3.9 and 5.6 %, respectively, and the variant at codon 879 with frequencies of 19.2 and 18.0 %, respectively. Each carrier of the codon 34 polymorphism was also a carrier of the codon 411 and codon 879 variants and similarly, carriers of the variant at codon 411 were also carriers of the polymorphism at codon 879. The variants at codon 584 and 883 were each found in only one Type II diabetic patient. The allelic frequencies of the variants at codon 411 and 879 were also determined in 380 young healthy subjects (4.6 and 18.1 %, respectively). The insulin sensitivity index as estimated by Bergman's minimal model of the young healthy subjects carrying either polymorphism was indistinguishable from the carriers of wild-type IRS-4. Moreover, none of the men were heterozygous for the IRS-4 polymorphisms indicating that the gene is located on the X-chromosome. In conclusion, amino acid polymorphisms in human IRS-4 are common in Caucasians but are not associated with Type II diabetes or with insulin resistance in young healthy subjects. [Diabetologia (1998) 41: 969–974]
Springer